세계의 장기칩(Organs-on-Chips) 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Organs-on-chips Market is presumed to reach the market size of nearly USD 1541.44 Million by 2032 from USD 117.26 Million in 2023 with a CAGR of 33.14% under the study period 2024 - 2032.

Organs-on-chips are microfluidic devices that replicate the structural and functional traits of human organs on a miniature scale. These chips contain living cells and simulate the physiological environment, allowing researchers to study organ-level responses to drugs and diseases. This technology offers a more accurate and ethical alternative to traditional animal testing, providing valuable insights into human biology for drug development and personalized medicine.

MARKET DYNAMICS

The increasing demand for alternatives to traditional animal testing methods due to ethical concerns and the need for more human-relevant research models drives adoption. Additionally, the focus on personalized medicine and drug development amplifies the significance of accurate in vitro testing platforms. The organs-on-chips technology offers a more physiologically relevant environment, enabling a better understanding of organ-level responses. Moreover, collaborations between pharmaceutical companies and organs-on-chips manufacturers contribute to market growth, fostering innovation and research. The push for precision medicine, coupled with advancements in microfabrication techniques, further accelerates market expansion. As the pharmaceutical and biotechnology industries prioritize safer and more efficient drug development processes, the organs-on-chips market is poised for sustained growth, revolutionizing the landscape of preclinical testing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organs-on-chips. The growth and trends of organs-on-chips industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the organs-on-chips market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products)
• Service

By Material

• Polydimethylsiloxane (Pdms)
• Polymer
• Glass

By Model Type

• Single-Organ Model
• Multi-Organ Model

By Application

• Drug Discovery
• Toxicity Testing
• Disease Modeling
• Personalized Medicine
• Other

By End-User

• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Organs-on-chips market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organs-on-chips market include Altis Biosystems, AlveoliX AG, Axosim, Bi/ond Solutions B.V, Cherry Biotech, CN-Bio, Emulate, Inc., Hesperos, Inc., Insphero, MesoBioTech, Mimetas B.V., Nortis Inc., React4Life, TARA Biosystems (Valo Health), TissUse GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ORGANS-ON-CHIPS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Material
  • 3.7.3 Market Attractiveness Analysis By Model Type
  • 3.7.4 Market Attractiveness Analysis By Application
  • 3.7.5 Market Attractiveness Analysis By End-User
  • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 Product (Liver-On-Chip, Lung-On-Chip, Heart-On-Chip, Kidney-On-Chip, Other Products) Historic and Forecast Sales by Regions
• 5.5 Service Historic and Forecast Sales by Regions

6 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY MATERIAL

• 6.1 Overview by Material
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Material
• 6.4 Polydimethylsiloxane (Pdms) Historic and Forecast Sales by Regions
• 6.5 Polymer Historic and Forecast Sales by Regions
• 6.6 Glass Historic and Forecast Sales by Regions

7 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY MODEL TYPE

• 7.1 Overview by Model Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Model Type
• 7.4 Single-Organ Model Historic and Forecast Sales by Regions
• 7.5 Multi-Organ Model Historic and Forecast Sales by Regions

8 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY APPLICATION

• 8.1 Overview by Application
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Application
• 8.4 Drug Discovery Historic and Forecast Sales by Regions
• 8.5 Toxicity Testing Historic and Forecast Sales by Regions
• 8.6 Disease Modeling Historic and Forecast Sales by Regions
• 8.7 Personalized Medicine Historic and Forecast Sales by Regions
• 8.8 Other Historic and Forecast Sales by Regions

9 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY END-USER

• 9.1 Overview by End-User
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End-User
• 9.4 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions
• 9.5 Academic And Research Institutes Historic and Forecast Sales by Regions
• 9.6 Other Historic and Forecast Sales by Regions

10 . GLOBAL ORGANS-ON-CHIPS MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. South East Asia Sales Analysis
  • 10.5.10. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE ORGANS-ON-CHIPS COMPANIES

• 11.1. Organs-On-Chips Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF ORGANS-ON-CHIPS INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Altis Biosystems
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. AlveoliX AG
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Axosim
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Bi/ond Solutions B.V
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Cherry Biotech
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. CN-Bio
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Emulate Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Hesperos Inc.
  • 12.10.1. Company Overview
  • 12.10.2. Company Revenue
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Insphero
  • 12.11.1. Company Overview
  • 12.11.2. Company Revenue
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. MesoBioTech
  • 12.12.1. Company Overview
  • 12.12.2. Company Revenue
  • 12.12.3. Products
  • 12.12.4. Recent Developments
• 12.13. Mimetas B.V.
  • 12.13.1. Company Overview
  • 12.13.2. Company Revenue
  • 12.13.3. Products
  • 12.13.4. Recent Developments
• 12.14. Nortis Inc.
  • 12.14.1. Company Overview
  • 12.14.2. Company Revenue
  • 12.14.3. Products
  • 12.14.4. Recent Developments
• 12.15. React4Life
  • 12.15.1. Company Overview
  • 12.15.2. Company Revenue
  • 12.15.3. Products
  • 12.15.4. Recent Developments
• 12.16. TARA Biosystems (Valo Health)
  • 12.16.1. Company Overview
  • 12.16.2. Company Revenue
  • 12.16.3. Products
  • 12.16.4. Recent Developments
• 12.17. TissUse GmbH.
  • 12.17.1. Company Overview
  • 12.17.2. Company Revenue
  • 12.17.3. Products
  • 12.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies